The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

DexCom Announces Upcoming Conference Presentations

Thursday, November 21, 2013

DexCom Announces Upcoming Conference Presentations

08:30 EST Thursday, November 21, 2013

SAN DIEGO (Business Wire) -- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

  • Terry Gregg, Chief Executive Officer, will present an update on DexCom at the 25th Annual Piper Jaffray Healthcare Conference in New York, New York on Tuesday, December 3, 2013 at 11:30 a.m. (EST). The presentation, which will occur live at The New York Palace Hotel, will be concurrently webcast.
  • Steve Pacelli, EVP, Strategy and Corporate Development will present an update on DexCom at the Oppenheimer 24th Annual Healthcare Conference in New York, New York on Tuesday, December 10, 2013 at 10:20 a.m. (EST). The presentation, which will occur live at The Crowne Plaza Hotel, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to “About,” then “Investor Relations,” and then “Events and Webcasts,” and the presentations will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements

DexCom is a medical device company with a limited operating history. Successful commercialization of the company's products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company's development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's quarterly report on Form 10-Q for the quarter ended September 30, 2013, as filed with the Securities and Exchange Commission on November 6, 2013.

DexCom, Inc.
Steven R. Pacelli, 858-200-0200
Executive Vice President, Strategy and Corporate Development

Products
  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Customer Service
Globe Recognition
Mobile Apps
NEWS APP
INVESTING APP
Other Sections